Literature DB >> 10567874

Cataract induced by short-term administration of large doses of busulfan: a case report.

T Kaida1, T Ogawa, T Amemiya.   

Abstract

Busulfan is a carcinostatic which is used for myelocytic leukemia. A 42-year-old Japanese woman given high doses of busulfan for a short time was referred to us because of decreased visual acuity and blurred vision in both eyes. She received 212 mg/day of busulfan for only 4 days. Ophthalmoscopic examination demonstrated a posterior polar subcapsular opacity of the lens in both eyes. Although the occurrence of cataract due to busulfan has been reported after long-term administration of busulfan, this is the first clinical case of cataract caused by high doses of busulfan for a short period. It is necessary to pay more attention to busulfan cataract. Copyright 1999 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567874     DOI: 10.1159/000027462

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  1 in total

Review 1.  Ocular toxicity of systemic anticancer chemotherapy.

Authors:  Afekhide Ernest Omoti; Caroline Edijana Omoti
Journal:  Pharm Pract (Granada)       Date:  2006-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.